DanaLukinMDPhD
Gastroenterology • New York, NYInflammatory Bowel Disease
Associate Professor of Medicine
Overview of Dr. Lukin
Dr. Dana Lukin is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lower Manhattan Hospital. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 9 years. He is one of 299 doctors at New York-Presbyterian Hospital and one of 41 doctors at NewYork-Presbyterian/Lower Manhattan Hospital who specialize in Gastroenterology. He also speaks multiple languages, including Spanish. He has more than 50 publications and over 500 citings.
Office
1283 York Avenue
9th Floor
New York, NY 10065- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2007 - 2010- Icahn School of Medicine at Mount SinaiClass of 2007, MD, PhD
Certifications & Licensure
NY State Medical License 2008 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- The Impact of Time Restricted Feeding in Crohn's Disease Start of enrollment: 2021 Jan 14
- Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients Start of enrollment: 2021 Feb 04
Publications & Presentations
PubMed
- The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis.Svetlana F Lima, Silvia Pires, Amanda Rupert, Seun Oguntunmibi, Wen-Bing Jin, Andrew Marderstein, Gabriela Funez-dePagnier, Grace Maldarelli, Monica Viladomiu, Gregory...> ;Cell Reports. Medicine. 2024 Mar 19
- An Unusual Hiccup: Severe Singultus as a Symptom in Ulcerative Colitis.Zaher, A., Hans, A., Lukin, D.> ;ACG Case Reports Journal. 2024 Jan 1
- Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease.Rochelle Wong, Lihui Qin, Yushan Pan, Prerna Mahtani, Randy Longman, Dana Lukin, Ellen Scherl, Robert Battat> ;Journal of Clinical Medicine. 2023 Oct 27
- Join now to see all
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Press Mentions
Upadacitinib Induction Provided Fast Symptom Relief in Ulcerative ColitisDecember 2nd, 2022- Higher Risk for Treatment Failure with Vedolizumab in Older IBD PatientsSeptember 30th, 2022
- TNF Inhibitors, Thiopurines May Help Reduce Recurrent Acute Arterial EventsJuly 19th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York- New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
NewYork-Presbyterian/Lower Manhattan HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
